The Utility of Mandatory Depression Screening of Dementia Patients in Nursing Homes

Cohen, Carl I.; Hyland, Kathryn; Kimhy, David

doi:10.1176/appi.ajp.160.11.2012

Cited by 50 publications

(42 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Whites are more likely than nonwhites to be given antidepressant medications. Depression screening has been shown to significantly increase the number of nonwhite depressed dementia patients receiving antidepressant medications (Cohen, Hyland, & Kimhy, 2003).…”

Section: Use Of Medicationsmentioning

confidence: 99%

Racial and Ethnic Disparities Among Individuals with Alzheimer’s Disease in the United States: A Literature Review

Lines¹,

Sherif²,

Wiener³

2014

115

View full text Add to dashboard Cite

This study reviews the published literature on racial and ethnic disparities among people with Alzheimer’s disease (AD) and related dementias in the United States. To identify relevant studies, we searched electronic sources for peer-reviewed journal articles and unpublished research reports that were published through July 2014; related to the AD population and their caregivers; and provided evidence of racial and ethnic disparities, discussed reasons for disparities, or described interventions to address disparities. The literature shows consistent and adverse disparities among blacks and Hispanics compared with non-Hispanic whites concerning AD, including the disease’s prevalence and incidence, mortality, participation in clinical trials, use of medications and other interventions, use of long-term services and supports, health care expenditures, quality of care, and caregiving. The literature suggests numerous underlying causes, including factors related to measurement of the disease, genetics, socioeconomic factors, cultural differences, lack of culturally competent clinicians, and discrimination. Although these disparities are well known, little is known about the effectiveness of various strategies, such as cultural competence training, to address these differences, and very few studies evaluate possible interventions.

show abstract

Section: Use Of Medicationsmentioning

confidence: 99%

Racial and Ethnic Disparities Among Individuals with Alzheimer’s Disease in the United States: A Literature Review

Lines¹,

Sherif²,

Wiener³

2014

115

View full text Add to dashboard Cite

show abstract

“…Depression has been reported to be underdetected and undertreated in nursing homes, especially among residents with dementia (Burrows et al, 1995;Teresi et al, 2001;Cohen et al, 2003;Gruber-Baldini et al, 2005). Bagley et al (2000) found low rates of recognition of depression by nursing and other care staff in long-term care facilities (15-27%, depending on the definition of depression used).…”

Section: Introductionmentioning

confidence: 99%

Recognising depression in residential facilities: an Australian challenge

Snowdon

Fleming

2007

Int J Geriat Psychiatry

View full text Add to dashboard Cite

show abstract

“…There has been widespread under-recognition of depression in nursing homes, especially among residents with dementia (Burrows et al, 1995;Cohen et al, 2003;Gruber-Baldini et al, 2005). Bagley et al (2000) reported that nursing and other care staff recognized depression in 15-27% of cases (varying according to the definition of depression).…”

Section: Recognition Of Depression In Nursing Homesmentioning

confidence: 99%

“…Bagley et al (2000) reported that nursing and other care staff recognized depression in 15-27% of cases (varying according to the definition of depression). Studies in the U.S.A. showed that less than 25% of cases of depression in nursing homes were identified and treated (Cohen et al, 2003). Introduction of mandatory screening with the Cornell Scale for Depression in Dementia (CSDD; Alexopoulos et al, 1988) resulted in a significantly increased proportion of depressed dementia patients receiving antidepressants (44% versus 20%; Cohen et al, 2003).…”

Section: Recognition Of Depression In Nursing Homesmentioning

confidence: 99%

Depression in nursing homes

Snowdon

2010

Int. Psychogeriatr.

View full text Add to dashboard Cite

Results of CSDD testing should prompt care staff (including doctors) to consider causation of depression in cases where residents are identified as possibly depressed. In particular, there needs to be discussion of how to help residents to cope with disability, losses, and feelings of powerlessness. Research is needed, examining factors that might predict response to antidepressants, and what else helps. Accreditation of nursing homes could be made to depend partly on evidence that staff regularly search for, and (if found) ensure appropriate responses to, depression.

show abstract

The Utility of Mandatory Depression Screening of Dementia Patients in Nursing Homes

Abstract: Mandatory depression screening can significantly increase the proportion of depressed dementia patients receiving antidepressants, lead to dose adjustments, diminish potential ethnic biases in treatment, and affect the depressive symptoms of treated individuals.

Cited by 50 publications

References 9 publications

Racial and Ethnic Disparities Among Individuals with Alzheimer’s Disease in the United States: A Literature Review

Racial and Ethnic Disparities Among Individuals with Alzheimer’s Disease in the United States: A Literature Review

Recognising depression in residential facilities: an Australian challenge

Depression in nursing homes

Contact Info

Product

Resources

About